Investigating a potential lymphoma-sink effect on CXCR4-targeted PET/CT for hematological malignancies, we evaluated a cohort of individuals diagnosed with MZL, which presented with a broad range of lymphoma load and in-vivo tracer uptake on PET. The gene discussed is CXCR4; the disease is hematologic disorder.